Overview

DDI Study of Etravirine and GSK1265744

Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to compare steady-state plasma PK, safety and tolerability of GSK1265744 with and without etravirine
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Cabotegravir
Etravirine